🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Humira ® Adalimumab

Found 132 matching trials

bIosimilar of aDalimumab, an European evAluation

N/A

The study objective is aimed to describe all country, site, investigator an...

Status

Unknown

Location

Multiple Locations

Start Date

2022-04-30

Trial ID

NCT05190484

Special Investigation in Patients With Ulcerative Colitis

N/A

This investigation will be conducted to obtain the following information re...

Status

Completed

Location

Multiple Locations

Start Date

2013-08-09

Trial ID

NCT01947816

Safety and Efficacy Study of Adalimumab in the Treatment of Plaque Psoriasis

PHASE3

A study to evaluate the safety and efficacy of adalimumab in Chinese subjec...

Status

Completed

Location

Site Reference ID/Investigator# 72888

Start Date

2012-08

Trial ID

NCT01646073

Treatments Being Tested

Adalimumab placebo

A Study of Subcutaneous HUMIRA (Adalimumab) Injection to Assess Adverse Events and Change in Disease Activity In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)

N/A

Crohn's disease (CD) is an incurable chronic inflammatory disorder of the g...

Status

Completed

Location

Peking University Third Hospital /ID# 242803

Start Date

2022-06-29

Trial ID

NCT05394805

Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service

N/A

This study aims to evaluate the impact of AbbVie Care 2.0 on adalimumab's c...

Status

Completed

Location

Instituto Portugues De Reumatologia /ID# 205963

Start Date

2017-11-15

Trial ID

NCT03223012

Special Investigation (Long-term Investigation) in Patients With Crohn's Disease

N/A

This study of Humira will be conducted to obtain information on the safety ...

Status

Completed

Location

Multiple Locations

Start Date

2011-12-16

Trial ID

NCT01464333

A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )

N/A

This is a five year, post-marketing observational study to follow-up patien...

Status

Completed

Location

Multiple Locations

Start Date

2004-05-13

Trial ID

NCT01078558

A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.

PHASE2

Hidradenitis suppurativa (HS) is a painful, long-term skin condition that c...

Status

Completed

Location

Hs0001 121

Start Date

2017-09-22

Trial ID

NCT03248531

Treatments Being Tested

Bimekizumab Adalimumab Placebo

A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)

N/A

This is a registry study to evaluate the long-term safety and effectiveness...

Status

Active Not Recruiting

Location

Univ Alabama, Birmingham CCC /ID# 146060

Start Date

2014-08-28

Trial ID

NCT02130362

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

PHASE2

This study seeks to evaluate the safety and efficacy of brazikumab versus p...

Status

Terminated

Location

Research Site

Start Date

2018-12-07

Trial ID

NCT03759288

Treatments Being Tested

Brazikumab low dose Brazikumab high dose Humira®Placebo

Previous Next